Lantheus Holdings (LNTH)

$65.84 -1.64 (-2.43%)
Market Cap 4.47B
Revenue (ttm) 1.53B
Net Income (ttm) 312.44M
EPS (ttm) N/A
PE Ratio 13.65
Forward PE 14.21
Profit Margin 20.37%
Debt to Equity Ratio 0.51
Volume 879,500
Avg Vol 1,154,262
Day's Range N/A - N/A
Shares Out 66.31M
Stochastic %K 25%
Beta -0.11
Analysts Strong Sell
Price Target $83.85

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 978 671 8001
Fax: 978 671 8860
Address:
201 Burlington Road, South Building, Bedford, United States
WilliamBalding588
WilliamBalding588 Jan. 12 at 6:04 PM
$LNTH $ABT Diagnostics focus
0 · Reply
11thestate
11thestate Jan. 12 at 2:38 PM
Meanwhile, the $LNTH case is moving forward — and now we’ve got more details. We pulled out the most important points for you. As always — worth a look: https://11th.com/cases/lantheus-investor-suit
1 · Reply
IanMaui
IanMaui Jan. 9 at 6:20 PM
$RADX IMO The Aktis IPO today is a major catalyst to the future acqusition of RADX by $LNTH 1. Eli Lilly investing $100M in phase 1 pipeline company 2. Heavy appetite in the IPO by institutional investors 3. Lantheus might fell pressure to complete an acq. sooner than later 4. LNTH just divested SPECT biz last week. They are "cash rich" and need growth engine(s). 5. I have been considering $300M mkt cap as an acq. price, but based on AKTS ipo, I believe RADX is worth north of $500-600M. 6. 7. What did I miss?
2 · Reply
IanMaui
IanMaui Jan. 9 at 6:01 PM
RADX The AKTS ipo raises the bar for RADX. We have Lilly with $100M investment and a 1B mkt cap with a green banana pipeline. I am moving an acquisition to $500-750M by Lantheus. 10X current mkt cap. $LNTH just sold off SPECTRE biz and is going all in on Dx & Tx now. $50 dollars is well within reach with this market validation from AKTS
0 · Reply
raj3406
raj3406 Jan. 9 at 3:53 PM
$LNTH Could not hold 70, so we will likely see 60 again, before we see 80.
1 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 9 at 1:36 AM
$AKTS $LNTH $RADX What’s being announced Aktis Oncology is planning a U.S. IPO and is targeting up to a ~$945 million valuation after upsizing the deal (meaning demand was strong enough to raise the size/price range). A comparison is being made to Radiopharm Theranostics ($RADX), which: • Trades at ~$60M valuation • Is further along in development of a B7-H3–targeted radiopharmaceutical • Has Lantheus Holdings ($LNTH) as a ~15% strategic owner ⸻ Why $LNTH is mentioned Lantheus: • Owns ~15% of RADX • Is a major player in radiopharmaceuticals • Acts as a strategic validator of companies in this space Therefore: BUY LNTH
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 9 at 1:15 AM
Aktis Oncology targets up to $945 million valuation in upsized. Peer $RADX trades at $60 million valuation with B7-H3 ahead of them and ownership by major radiopharmaceutical Lantheus at 15% $LNTH US IPO $AKTS https://www.msn.com/en-us/money/markets/aktis-oncology-targets-up-to-945-million-valuation-in-upsized-us-ipo/ar-AA1TKoSd?ocid=finance-verthp-feeds
1 · Reply
ZacksSCR
ZacksSCR Jan. 8 at 3:01 PM
$LNTH Lantheus Closes SPECT Sale buff.ly/2RM76mI
0 · Reply
Stackdoe1
Stackdoe1 Jan. 8 at 3:54 AM
$LNTH $120
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 7 at 8:02 PM
$LNTH how am I the only one posting this board when there are 3 pdufa’s this year for the hard pump? 67m shares. 92% locked up with tutes. $380 million Cash in bank. @PLATINUM_TRADES @Slingshot @ACInvestorBlog @dixiebull @SpartanVI @DekmarTrades @DonCorleone77 @MS_Tammy
1 · Reply
Latest News on LNTH
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Jan 2, 2026, 8:00 AM EST - 11 days ago

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

Dec 7, 2025, 11:21 AM EST - 5 weeks ago

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price

Nov 13, 2025, 9:28 AM EST - 2 months ago

The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price

Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update

Nov 13, 2025, 1:50 AM EST - 2 months ago

Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update

BRBR MMSI MNDY PI POWL PRM RMBS

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Nov 7, 2025, 9:48 AM EST - 2 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Lantheus Holdings, Inc. (LNTH) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 5:56 PM EST - 2 months ago

Lantheus Holdings, Inc. (LNTH) Q3 2025 Earnings Call Transcript

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 6, 2025, 7:02 AM EST - 2 months ago

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

LNTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Nov 4, 2025, 11:59 AM EST - 2 months ago

LNTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit – LNTH

Oct 30, 2025, 3:58 PM EDT - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit – LNTH

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Oct 28, 2025, 9:44 AM EDT - 2 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

Oct 27, 2025, 10:08 AM EDT - 2 months ago

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Oct 23, 2025, 1:03 PM EDT - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time

Oct 23, 2025, 8:30 AM EDT - 2 months ago

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time

LANTHEUS DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds Lantheus Holdings Investors to Contact the Firm Before the November 10th Deadline

Oct 15, 2025, 4:35 PM EDT - 3 months ago

LANTHEUS DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds Lantheus Holdings Investors to Contact the Firm Before the November 10th Deadline

Lantheus Holdings: Not An Easy Buy, But The Company Continues To Create Value

Oct 14, 2025, 6:07 AM EDT - 3 months ago

Lantheus Holdings: Not An Easy Buy, But The Company Continues To Create Value

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit - LNTH

Oct 6, 2025, 8:45 AM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit - LNTH

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Lawsuit - LNTH

Sep 25, 2025, 8:45 AM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Lawsuit - LNTH

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Sep 24, 2025, 1:00 AM EDT - 4 months ago

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Sep 22, 2025, 5:29 AM EDT - 4 months ago

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information

Sep 19, 2025, 6:33 PM EDT - 4 months ago

Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (LNTH)

Sep 10, 2025, 8:00 PM EDT - 4 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (LNTH)

LNTH LAWSUIT: Lantheus Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses

Sep 10, 2025, 10:54 AM EDT - 4 months ago

LNTH LAWSUIT: Lantheus Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses

Lantheus Holdings, Inc. (LNTH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 10:09 AM EDT - 4 months ago

Lantheus Holdings, Inc. (LNTH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

Sep 3, 2025, 8:55 PM EDT - 4 months ago

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:09 PM EDT - 5 months ago

Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript

Lantheus Holdings: Reassessing The Buy Thesis

Aug 6, 2025, 10:09 AM EDT - 5 months ago

Lantheus Holdings: Reassessing The Buy Thesis

WilliamBalding588
WilliamBalding588 Jan. 12 at 6:04 PM
$LNTH $ABT Diagnostics focus
0 · Reply
11thestate
11thestate Jan. 12 at 2:38 PM
Meanwhile, the $LNTH case is moving forward — and now we’ve got more details. We pulled out the most important points for you. As always — worth a look: https://11th.com/cases/lantheus-investor-suit
1 · Reply
IanMaui
IanMaui Jan. 9 at 6:20 PM
$RADX IMO The Aktis IPO today is a major catalyst to the future acqusition of RADX by $LNTH 1. Eli Lilly investing $100M in phase 1 pipeline company 2. Heavy appetite in the IPO by institutional investors 3. Lantheus might fell pressure to complete an acq. sooner than later 4. LNTH just divested SPECT biz last week. They are "cash rich" and need growth engine(s). 5. I have been considering $300M mkt cap as an acq. price, but based on AKTS ipo, I believe RADX is worth north of $500-600M. 6. 7. What did I miss?
2 · Reply
IanMaui
IanMaui Jan. 9 at 6:01 PM
RADX The AKTS ipo raises the bar for RADX. We have Lilly with $100M investment and a 1B mkt cap with a green banana pipeline. I am moving an acquisition to $500-750M by Lantheus. 10X current mkt cap. $LNTH just sold off SPECTRE biz and is going all in on Dx & Tx now. $50 dollars is well within reach with this market validation from AKTS
0 · Reply
raj3406
raj3406 Jan. 9 at 3:53 PM
$LNTH Could not hold 70, so we will likely see 60 again, before we see 80.
1 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 9 at 1:36 AM
$AKTS $LNTH $RADX What’s being announced Aktis Oncology is planning a U.S. IPO and is targeting up to a ~$945 million valuation after upsizing the deal (meaning demand was strong enough to raise the size/price range). A comparison is being made to Radiopharm Theranostics ($RADX), which: • Trades at ~$60M valuation • Is further along in development of a B7-H3–targeted radiopharmaceutical • Has Lantheus Holdings ($LNTH) as a ~15% strategic owner ⸻ Why $LNTH is mentioned Lantheus: • Owns ~15% of RADX • Is a major player in radiopharmaceuticals • Acts as a strategic validator of companies in this space Therefore: BUY LNTH
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 9 at 1:15 AM
Aktis Oncology targets up to $945 million valuation in upsized. Peer $RADX trades at $60 million valuation with B7-H3 ahead of them and ownership by major radiopharmaceutical Lantheus at 15% $LNTH US IPO $AKTS https://www.msn.com/en-us/money/markets/aktis-oncology-targets-up-to-945-million-valuation-in-upsized-us-ipo/ar-AA1TKoSd?ocid=finance-verthp-feeds
1 · Reply
ZacksSCR
ZacksSCR Jan. 8 at 3:01 PM
$LNTH Lantheus Closes SPECT Sale buff.ly/2RM76mI
0 · Reply
Stackdoe1
Stackdoe1 Jan. 8 at 3:54 AM
$LNTH $120
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 7 at 8:02 PM
$LNTH how am I the only one posting this board when there are 3 pdufa’s this year for the hard pump? 67m shares. 92% locked up with tutes. $380 million Cash in bank. @PLATINUM_TRADES @Slingshot @ACInvestorBlog @dixiebull @SpartanVI @DekmarTrades @DonCorleone77 @MS_Tammy
1 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 7 at 12:45 AM
$LNTH 95% shares locked up by tutes @GreggTwits
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 6 at 9:53 PM
$LNTH this is the one
0 · Reply
HappE
HappE Jan. 6 at 9:52 AM
$LNTH looking at weekly chart says it all. Accumulated big-time since the drop. We dont need the Memes to know what we own. Fundamental: been saying for last 1.5 years this is 26 and if fruitful huge 27 play. Rest is pumping.
0 · Reply
HappE
HappE Jan. 6 at 9:49 AM
$LNTH This ticker don't need the Memes. There's about two handfuls of us who know how to Hold. Buh bye member.
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 6 at 1:02 AM
$LNTH $70! !
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 5 at 6:17 PM
$LNTH
0 · Reply
TradingFUD
TradingFUD Jan. 5 at 3:38 PM
$LNTH GOING NUCLEAR DAILY MA: LANTHEUS, is about to hit the 200 MA, $70.40. Once that MA band breaks, the chart will move towards $73. $LNTH is in phase 1 of chart breakout. Upcoming #PDUFA & quarterly results will help the momentum. Neuraceq sales will be juicy this year‼️ $XBI
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 5 at 2:59 PM
$LNTH
0 · Reply
Estimize
Estimize Jan. 5 at 12:00 PM
Wall St is expecting 1.16 EPS for $LNTH Q4 [Reporting 02/19 BMO] http://www.estimize.com/intro/lnth?chart=historical&metric_name=eps&utm_co
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 4 at 2:03 AM
Riccardo Canevari - 2nd TRP Target Selection & Drug Design Summit 2026 $RADX $CATX $LNTH https://targeted-radiopharma-target-selection-drug-design.com/speaker/riccardo-canevari/
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 3 at 8:12 PM
Top 20 Radiopharmaceutical Companies of 2025 - PharmaShots $LNTH $CLRB $RADX $CATX https://pharmashots.com/21516/top-20-radiopharmaceutical-companies-of-2025/
2 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Jan. 3 at 3:00 AM
$LNTH follow the trajectory !!! Multiple PDUFA’s in 2026
0 · Reply